by Eric Christianson | Oct 6, 2024 | Clinical Pharmacy News and New Drug Updates, Women’s and Men’s Health Medication and Disease State Clinical Pearls
Fezolinetant (Veozah) is a central nervous system agent that works as an antagonist at the neurokinin 3 (NK3) receptor. This action inhibits neurokinin B (NKB) binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron which alters activity in the thermoregulatory...
by Eric Christianson | Oct 2, 2024 | Clinical Pharmacy News and New Drug Updates
The FDA has been busy this year reviewing new medications. As a practicing pharmacist, it is hard to remember everything so I wanted to outline the top 5 drug approvals in 2024 that may impact ambulatory care and geriatrics. Without further ado, here’s my top 5...
by Eric Christianson | Sep 29, 2024 | Gastrointestinal Medication and Disease State Clinical Pearls
Proton Pump Inhibitors are one of the most commonly used medication classes for GERD and other gastrointestinal disorders. While they don’t have a ton of significant drug interactions, there are some important ones that you should know. I outline my top 5 PPI...
by Eric Christianson | Sep 25, 2024 | Long Term Care Consultant Pharmacist Education and Information
As a consultant pharmacist, I always try to stay on top of trends to help nursing homes stay on top of guidelines and best practices. With the help of a student, we reviewed 50 LTC facility surveys and share the findings of the most common 2024 nursing home survey...
by Eric Christianson | Sep 22, 2024 | Endocrine Medication and Disease State Clinical Pearls
Fluctuations in blood sugars can be very distressing for patients. This is especially true in patients who have adequate control of their diabetes. Adverse effects can lead to an escalation of diabetes medication. I’ll share my top 5 drugs that cause...
